CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy

CONCLUSION: CD8+MAIT cells are a potential predictive biomarker for patients with NSCLC responding to anti-PD-1 therapy. The correlation between CD8+MAIT cells and immunotherapy sensitivity may be ascribed to high CXCR6 expression.PMID:38698468 | DOI:10.1186/s13046-024-03046-3

Source: Cell Research - May 2, 2024 Category: Cytology Authors: Jingjing Qu Binggen Wu Lijun Chen Zuoshi Wen Liangjie Fang Jing Zheng Qian Shen Jianfu Heng Jianya Zhou Jianying Zhou Source Type: research